Department of Cardiovascular Surgery, JA Hiroshima General Hospital, Hiroshima, Japan.
Department of Cardiovascular Surgery, JA Hiroshima General Hospital, Hiroshima, Japan.
Eur J Vasc Endovasc Surg. 2021 Jan;61(1):121-127. doi: 10.1016/j.ejvs.2020.09.021. Epub 2020 Oct 13.
Although distal bypass using vein has been established with acceptable outcomes for chronic limb threatening ischaemia (CLTI), the major issue affecting long term outcomes is vein graft disease. This study aimed to analyse the peri-procedural results and long term outcomes of endovascular therapy (EVT) for failing vein grafts after distal bypass.
A retrospective analysis of 113 failing vein grafts (94 patients, 113 limbs) after distal bypass between 2009 and 2019 at the study hospital.
The mean age was 74 ± 9 years and 72% of the patients were men. Of the 113 grafts, 54 grafts (48%) were detected in asymptomatic patients, 41 grafts (36%) in patients with recurrent ulcer or gangrene, and 18 grafts (16%) in patients with rest pain. The failing grafts were treated by low pressure long inflation balloon angioplasty with a mean balloon size of 3.0 ± 0.8 mm. The mean procedural time was 60 ± 29 min and procedural success was 98% (111 grafts). During the mean follow up period of 34 months, EVT was performed a median frequency of two times (range 1-11 times). The primary and assisted primary patency of the EVT revised grafts were 41% and 80% at one year, 34% and 68% at three years, 31% and 58% at five years, respectively. Of 41 limbs with recurrent ulcer or gangrene, the wound healed in 34 limbs (85%). The complete healing rate was 71% at three months and 84% at 12 months. Eight patients required major amputation, and the freedom from major amputation rate was 96% at one year and 80% at five years.
Long term outcomes including patency, wound healing rate, and amputation free survival after EVT for failing vein grafts were acceptable. EVT could be a viable alternative to surgical revascularisation in patients with a failing distal bypass graft for CLTI.
尽管使用静脉进行远端旁路移植术已在治疗慢性肢体威胁性缺血(CLTI)方面取得了可接受的结果,但影响长期结果的主要问题是静脉移植物病变。本研究旨在分析远端旁路术后静脉移植物失败的腔内治疗(EVT)的围手术期结果和长期结果。
回顾性分析 2009 年至 2019 年期间在研究医院接受远端旁路术后静脉移植物失败的 113 例(94 例患者,113 条肢体)。
患者的平均年龄为 74±9 岁,72%为男性。在 113 个移植物中,54 个(48%)在无症状患者中发现,41 个(36%)在复发性溃疡或坏疽患者中发现,18 个(16%)在静息痛患者中发现。失败的移植物通过低压长膨胀球囊血管成形术治疗,平均球囊大小为 3.0±0.8mm。手术时间平均为 60±29 分钟,手术成功率为 98%(111 个移植物)。在平均 34 个月的随访期间,EVT 治疗中位数频率为 2 次(范围 1-11 次)。EVT 修正移植物的主要和辅助通畅率在 1 年时分别为 41%和 80%,在 3 年时分别为 34%和 68%,在 5 年时分别为 31%和 58%。在 41 例复发性溃疡或坏疽的肢体中,34 例(85%)的伤口愈合。3 个月时完全愈合率为 71%,12 个月时为 84%。8 例患者需要进行大截肢,1 年时大截肢率为 96%,5 年时为 80%。
EVT 治疗静脉移植物失败的长期结果,包括通畅率、愈合率和免于截肢的生存率,是可以接受的。对于 CLTI 患者的远端旁路移植术失败,EVT 可能是一种可行的血管重建替代方法。